The Effectiveness of Intravitreal Avastin Injection for CRVO

This study is currently recruiting participants.
Verified August 2012 by Ziv Hospital
Sponsor:
Information provided by (Responsible Party):
Ziv Hospital
ClinicalTrials.gov Identifier:
NCT01678248
First received: August 29, 2012
Last updated: NA
Last verified: August 2012
History: No changes posted
  Purpose

to determine the effectivness of intravitreal avastin injection on visual acuity on people that suffer from central retinal vein occlusion


Condition
Central Retinal Vein Occlusion

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Effectiveness of Intravitreal Avastin Injection for CRVO

Further study details as provided by Ziv Hospital:

Estimated Enrollment: 68
Study Start Date: January 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

patients who suffer from CRVO and were injected by bevazicumab intravitrealy

Criteria

Inclusion Criteria:

  • patients above 18 years old
  • suffer from CRVO
  • maximal visual acuity 6/15

Exclusion Criteria:

  • VA of LP
  • retinal disease other than CRVO
  • incomplete medical record
  • follow up less than 6 months
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01678248

Contacts
Contact: Joseph pikkel, M.D 972508434206 pikel.y@ziv.health.gov.il
Contact: Otzem Chassid, M.D 972506266059 otzem.c@ziv.health.gov.il

Locations
Israel
Ziv Medical Center Recruiting
Safed, Israel, 13100
Contact: Otzem Chassid, M.D       otzem.c@ziv.health.gov.il   
Principal Investigator: Joseph Pikkel, M.D         
Sponsors and Collaborators
Ziv Hospital
  More Information

No publications provided

Responsible Party: Ziv Hospital
ClinicalTrials.gov Identifier: NCT01678248     History of Changes
Other Study ID Numbers: 0048-12-ZIV
Study First Received: August 29, 2012
Last Updated: August 29, 2012
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Retinal Vein Occlusion
Retinal Diseases
Eye Diseases
Venous Thrombosis
Thrombosis
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on April 17, 2014